Hormonal therapies such as tamoxifen, or a class of drugs called aromatase inhibitors, can reduce the likelihood that women diagnosed with certain breast cancers will experience a recurrence of their disease. However, a new study finds these treatments — used in breast cancers that are responsive to hormones such as estrogen — are too seldom utilized or often used incorrectly. According to the research team, if all U.S. breast cancer survivors who needed them followed recommendations for hormone therapy, that could mean almost 15,000 lives saved over a decade. Unfortunately, these drugs are “still underused, and in some cases, misused — offered to patients who lack [estrogen] hormone receptors” on their tumor cells, explained study senior author Dr. Dezheng Huo. He’s associate professor of public health sciences at the University of Chicago. Source: HealthDay, February 2, 2017
Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.
WEBINAR -- Cancer Coalition Identity, Branding, and Marketing -- Presented by American Cancer Society in partnership with the National Association of Chronic Disease Directors -- Wednesday, September 20, 2017 3 p.m. EDT -- SAVE THE DATE
Spirit of EAGLES National Conference "Changing Patterns of Cancer in Native Communities" - September 21 - 24, 2017 - Niagra Falls, NY - For more information regarding the conference, visit www.nativeamericanprograms.net or contact Marcy Averill at firstname.lastname@example.org.
Tenth AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved - September 25-28, 2017, Sheraton Atlanta Hotel, Atlanta, Georgia - The AACR Cancer Health Disparities conferences advance the understanding and, ultimately, help to eliminate the disparities in cancer that represent a major public health problem in our country. By promoting the exchange of novel ideas and information between a wide range of professionals from academia, industry, government, and the community, these conferences harness the potential and maximize the many opportunities for bringing research on health disparities from bench to bedside or community, and back again. The goals of these conferences have been to bring together scientists and other professionals working in a variety of disciplines to discuss the latest findings in the field and to stimulate the development of new research in cancer health disparities. Make plans now to join us for this exciting program. - Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
Webinar Series - The National Behavioral Health Network is hosting a series of webinars. - Finding New Financing for Tobacco Cessation & Cancer Prevention Efforts - LEARN MORE
Event - November 27-28, 2017 - Cancer Survivorship Symposium - CLICK HERE FOR INFO AND TO REGISTER.